Related Experiment Video
Updated: May 24, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
Current challenges surrounding exosome treatments
Eileen Tzng1, Nathan Bayardo1, Phillip C Yang1
1Division of Cardiovascular Medicine and Cardiovascular Institute, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, United States of America.
Insights
Exosomes show promise for treating cardiovascular disease by improving heart function after injury. Challenges in exosome therapy, including standardization and clinical application, require further research for effective precision medicine.
Area of Science:
- Cardiovascular research
- Regenerative medicine
- Biotechnology
Background:
- Cardiovascular disease is a leading global cause of mortality.
- Exosomes demonstrate potential in improving cardiac function post-myocardial injury.
- Exosome therapy offers a precision medicine approach by targeting disease mechanisms.
Purpose of the Study:
- To explore the therapeutic potential of exosome therapy for cardiovascular diseases.
- To address key challenges hindering the clinical application of exosome therapy.
- To summarize biological plausibility, delivery, dosing, pharmacokinetics, and manufacturing of exosomes.
Main Methods:
- Review of existing studies on exosome therapy for cardiovascular conditions.
- Analysis of challenges including zeta potential, standardization, and regulation.
- Focus on microRNA as a critical molecular cargo within exosomes.
Main Results:
- Exosomes exhibit multiple mechanisms to enhance cardiac function after myocardial injury.
- Significant challenges exist for the clinical translation of exosome therapy.
- MicroRNA content is crucial for exosome-mediated therapeutic effects.
Conclusions:
- Exosome therapy holds significant promise for cardiovascular disease treatment.
- Overcoming challenges in standardization, manufacturing, and clinical application is essential.
- Further research is needed to optimize exosome-based precision medicine for cardiac repair.
Abstract:
Cardiovascular disease is the leading cause of death worldwide today and numerous studies are demonstrating that exosomes improve cardiac function after myocardial injury through various mechanisms. Exosome therapy has great potential as an effective precision medicine biologic by targeting the underlying disease process. However, this innovative approach may face some challenges, such as zeta potential, standardization of exosome collection, biopharmaceutical regulation, and more importantly, specific clinical application of exosome therapy. These issues will be addressed by broadly summarizing the biological plausibility; delivery, dosing, and pharmacokinetics; and reproducibility and manufacturing with a focus on microRNA as molecular cargo.
More Related Videos
09:30Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
05:36Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles
Published on: January 26, 2024